Product Details for: Ocrevus

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
300MG/10ML (30MG/ML)
Single-Dose Vial
351(a)
Ocrevus
Rx
Proper Name
ocrelizumab
BLA Number
761053
Applicant
Genentech, Inc.
Original Approval Date
March 28, 2017
Date of First Licensure
RETURN TO SEARCH RESULTS